The effects of normal aging and ApoE genotype on the levels of CSF biomarkers for Alzheimer's disease
Lidia Głodzik-Sobańska(New York University), Mony J. de Leon(Cornell University), Pankaj Mehta, Remigiusz Switalski(New York University), Kaj Blennow(Sahlgrenska University Hospital), Susan De Santi, Kenneth Rich(New York University), Frank Martiniuk(Psychogenics (United States)), Elizabeth Pirraglia(New York University), Domenico Praticò(University of Pennsylvania), Martin Sadowski(New York University), Lisa Mosconi(Cornell University), Leslie Saint Louis(New York University), Raymond Zinkowski, Mirosław Bryś(Eli Lilly (United States))
Cited by 94
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
|Alzheimer s & Dementia|2014|3.1k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k